Cochrane

Protocol: To evaluate the effectiveness of antiretroviral resistance testing (genotypic or phenotypic) in reducing mortality and morbidity in people living with HIV.

Why did we do this review? HIV is still a major cause of death worldwide, particularly in Africa. HIV multiplies in the blood and damages the immune system. Therefore if HIV-positive, one is more vulnerable to contract infections. The current drug treatment, antiretroviral therapy (ART), stops the virus from multiplying thereby allowing the body's ...

Cochrane researchers conducted a review of the effects of micronutrient supplements for people living with HIV. This is an update of a Cochrane Review previously published in 2010. After searching for relevant trials up to 18 November 2016, the review authors included 33 trials. Thirteen of these trials included people not on HIV treatment and were ...

Pneumocystis jiroveci pneumonia (PCP), formerly called Pneumocystis carinii pneumonia, is the most common opportunistic infection among patients infected with HIV. In 1990, based on evidence from five randomised controlled trials, an expert panel recommended the use of corticosteroids for HIV-infected patients with PCP and substantial hypoxaemia (low ...

Stavudine has been the most widely used antiretroviral agent as part of the combination therapy for treating HIV-1 infection in low-income countries. The use of stavudine has been associated with complications of redistribution of fat in the body, abnormalities in insulin and lipids, lactic acidosis and nerve problems. Some of these complications may ...

Study Question This review seeks to determine whether vaccine for hepatitis B virus is effective in protecting people who have HIV against hepatitis B virus infection. It also seeks to determine if the vaccine is safe in people living with HIV. Background Hepatitis B virus infection can be acquired through contact with body fluids of infected people. ...

Worldwide, the primary cause of human immunodeficiency virus (HIV) infection in children is mother-to-child transmission (MTCT). MTCT of HIV can occur during pregnancy, around the time of delivery, or through breastfeeding. Great strides have been made in reducing MTCT during pregnancy and around the time of delivery. However, without intervention, ...

Protocol: Primary objectives: To assess the effects of self-management interventions for adults living with HIV in improving quality of life, psychological health outcomes, and health status.   Secondary objectives: To determine the effect of self-management programs on activity levels, health care utilisation, risk-taking behaviour, and experience ...

Kaposi’s sarcoma was the first tumor to be described in association with HIV infection and is an AIDS-defining condition. It is also known as Kaposi's sarcoma-associated herpes virus (KSHV) as Herpes virus 8 (HHV8) is recognized as an essential and necessary factor in the pathogenesis of KS. Nonetheless, not all HHV-8-infected individuals will develop ...

HIV/AIDS Group Yuqing Zhang Wednesday, May 5, 2010 ...